Lauren Sabella
2017
In 2017, Lauren Sabella earned a total compensation of $1.5M as Chief Commercial Officer at Acorda Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $114,503 |
|---|---|
| Option Awards | $635,285 |
| Salary | $428,833 |
| Stock Awards | $302,225 |
| Other | $7,950 |
| Total | $1,488,796 |
Sabella received $635.3K in option awards, accounting for 43% of the total pay in 2017.
Sabella also received $114.5K in non-equity incentive plan, $428.8K in salary, $302.2K in stock awards and $8K in other compensation.
Rankings
In 2017, Lauren Sabella's compensation ranked 7,023rd out of 14,666 executives tracked by ExecPay. In other words, Sabella earned more than 52.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,023 out of 14,666 | 52nd |
Division Manufacturing | 2,607 out of 5,772 | 55th |
Major group Chemicals And Allied Products | 846 out of 2,075 | 59th |
Industry group Drugs | 659 out of 1,731 | 62nd |
Industry Biological Products, Except Diagnostic Substances | 122 out of 313 | 61st |
Source: SEC filing on April 27, 2018.
Sabella's colleagues
We found five more compensation records of executives who worked with Lauren Sabella at Acorda Therapeutics in 2017.
2017
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2017
Andrew Hindman
Acorda Therapeutics
Chief Business Officer
2017
Burkhard Blank
Acorda Therapeutics
Chief Medical Officer
2017
Jane Wasman
Acorda Therapeutics
General Counsel
2017
David Lawrence
Acorda Therapeutics
Chief, Business Operations and Principal Accounting Officer
News
Acorda Therapeutics CEO Ron Cohen's 2022 pay falls 40% to $984K
April 27, 2023
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019